Relaxin enhances in-vitro invasiveness of breast cancer cell lines by up-regulation of matrix metalloproteases

Molecular Human Reproduction

Volumn 8, Issue 9, 2002, Pages 789-796

  Binder, C ^a   Hagemann, Th ^a   Husen, B ^b   Schulz, M ^a   Einspanier, A ^b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b GERMAN PRIMATE CENTER   (Germany)

Author keywords

Breast cancer; Invasion; Matrix metalloproteases; Relaxin

Indexed keywords

COLLAGENASE 3; EPIDERMAL GROWTH FACTOR; FN 439; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MACROPHAGE ELASTASE; MATRILYSIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE INHIBITOR; MESSENGER RNA; NEUTROPHIL COLLAGENASE; RELAXIN; STROMELYSIN; STROMELYSIN 2; STROMELYSIN 3; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TISSUE INHIBITOR OF METALLOPROTEINASE 4; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INVASION; CONTROLLED STUDY; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TIME; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPRODUCTION; SOLID TUMOR; TUMOR GROWTH; ZYMOGRAPHY;

MINK CELL FOCUS-FORMING VIRUS; SUIDAE;

EID: 0036712077     PISSN: 13609947     EISSN: None     Source Type: Journal    
DOI: 10.1093/molehr/8.9.789     Document Type: Article

References (49)

1. Specific expression of matrix metalloproteinases 1, 3, 9 and 13 associated with invasiveness of breast cancer cells in vitro
2. Morphological changes induced on mouse mammary gland by porcine and human relaxin
3. Relaxin promotes differentiation of human breast cancer cells MCF-7 transplanted into nude mice
4. Reproductive state of rat mammary gland stroma modulates human breast cancer cell migration and invasion
5. Induction of inducible nitric oxide synthase is an essential part of tumor necrosis factor-α-induced apoptosis in MCF-7 and other epithelial tumor cells
6. High serum concentrations of relaxin correlate with dissemination of breast cancer
7. Relaxin levels in the human: An indicator of target storage and production sites
8. Matrix-metalloproteinases 1, 2 and 3 and their tissue inhibitors 1 and 2 in benign and malignant breast lesions: An in situ hybridization study
9. High levels of stromelysin-3 correlate with poor prognosis in patients with breast carcinoma
10. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
11. Activity of type IV collagenases in benign and malignant breast disease
12. Local relaxin biosynthesis in the ovary and uterus through the oestrous cycle and early pregnancy in the female marmoset monkey (Callithrix jacchus)
13. Proteolysis in human breast and colorectal cancer
14. Overview of matrix metalloproteinase expression in cultured human cells
15. Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis
16. Differential mRNA expression profile of matrix metalloproteases and their inhibitors in subtypes of renal cell carcinomas
17. Relaxin-like factor (RLF) is differentially expressed in the normal and neoplastic human mammary gland
18. Activation of orphan receptors by the hormone relaxin
19. Coupling of dual signaling pathways: Epidermal growth factor action involves the estrogen receptor
20. Significance of membrane type 1 matrix metalloproteinase expression in breast cancer
21. Targeted induction of collagenase and stromelysin by relaxin in unprimed and beta-estradiol-primed diarthrodial joint fibrocartilaginous cells but not in synoviocytes
22. The insulin-like growth factor axis and prostate cancer: Lessons learned from the transgenic adenocarcinoma of the mouse prostate (TRAMP) model
23. The effects of estrogens, progestagens and relaxin in pregnant and nonpregnant laboratory rodents
24. Expression of matrix metalloproteinases and their tissue inhibitors in human brain tumors
25. Relaxin increases secretion of matrix metalloproteinase-2 and matrix metalloproteinase-9 during uterine and cervical growth and remodelling in the pig
26. Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells
27. Insulin-like growth factor I-triggered cell migration and invasion are mediated by matrix metalloproteinase-9
28. Epidermal growth factor and basic fibroblast growth factor increase the production of matrix metalloproteinases during in vitro decidualization of rat endometrial stromal cells
29. Differential modulation of proliferation, matrix metalloproteinase expression and invasion of human head and neck squamous carcinoma cells by c-erbB ligands
30. Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas
31. Relaxin stimulates uterine edema via activation of estrogen receptors: Blockade of its effects using ICI 182.780, a specific estrogen receptor antagonist
32. An autocrine/paracrine role of human decidual relaxin, II. Stromelysin-1 (MMP-3) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1)
33. Activation of matrix metalloproteinase 9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion
34. Selection of potentially metastatic subpopulations expressing c-erbB-2 from breast cancer tissue by use of an extravasation model
35. Increased expression of matrix metalloproteinases MMP-2, MMP-9 and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer
36. Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to overall survival of patients with gastric carcinomas
37. Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues
38. Matrix metalloproteinase-2 immunoreactive protein: A marker of aggressiveness in breast carcinoma
39. Human relaxin in normal, benign and neoplastic breast tissue
40. Activation of the precursor of gelatinase A/72 kDa type IV collagenase/MMP-2 in lung carcinomas correlates with the expression of membran-type matrix metalloproteinase (MT-MMP) and with lymph node metastasis
41. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas
42. Relaxin alone and in conjunction with interferon-γ decreases collagen synthesis by human scleroderma fibroblasts
43. Relaxin induces an extracellular matrix-degrading phenotype in human lung fibroblasts in vitro and inhibits lung fibrosis in a murine model in vivo
44. Progelatinase A mRNA expression in cell lines derived from tumors in patients with metastatic renal cell carcinoma correlates inversely with survival
45. SV 40 transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages
46. Prediction of colorectal cancer relapse and survival via tissue RNA levels of matrix metalloproteinase-9
47. Matrix metalloproteinase-7 expression in colorectal cancer liver metastases: Evidence for involvement of MMP-7 activation in human cancer metastases
48. Mice without a functional relaxin gene are unable to deliver milk to their pups
49. Collagen studies in late pregnant relaxin null mice